Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Challenge: Developing novel diagnostic strategies

Oxford researchers are using polygenic risk scores to guide clinical decision-making leading up to, and after a diagnosis of cancer. This is being achieved by developing individualised risk scores compared with general population risk and alongside other established clinical and molecular markers.